Comparison of the in vitro susceptibility of veterinary antibiotics with human antibiotics within aminoglycosides, β-lactam and fluoroquinolone antibiotic classes to highly resistant Gram-negative pathogens from human medicine.
J E
JE
Moore
M
M
Alcorn
J C
JC
Rendall
D G
DG
Downey
D000617:Aminoglycosides / Q000494:pharmacology*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D057508:Burkholderia cenocepacia / Q000187:drug effects / Q000254:growth & development; D024901:Drug Resistance, Multiple, Bacterial; D016972:Enterobacter cloacae / Q000187:drug effects / Q000254:growth & development; D004926:Escherichia coli / Q000187:drug effects / Q000254:growth & development; D024841:Fluoroquinolones / Q000494:pharmacology*; D006801:Humans; D041121:Klebsiella oxytoca / Q000187:drug effects / Q000254:growth & development; D007711:Klebsiella pneumoniae / Q000187:drug effects / Q000254:growth & development; D008826:Microbial Sensitivity Tests; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000254:growth & development; D018581:Technology Transfer; D006113:United Kingdom; D019155:Veterinary Drugs / Q000494:pharmacology*; D047090:beta-Lactams / Q000494:pharmacology*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D019155:Veterinary Drugs; D047090:beta-Lactams